HLA-B and chronic kidney disease: The dose will need to be adjusted in patients with chronic kidney disease. After initiating treatment, serum urate levels can be monitored every two to three weeks, after which the allopurinol dose can be adjusted to reach the goal serum urate levels. Prior to initiating treatment, patients who are of Asian or African descent are evaluated for the HLA-B*5801 allele.